Home › Funds › Foster Victor Wealth Advisors, LLC › GSK
Foster Victor Wealth Advisors, LLC position in GSK
GSK PLC · Health Care
Foster Victor Wealth Advisors, LLC reported holding 438,220 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$21.7M, representing 1.09% of its reported portfolio and ranking #23 among its reported holdings. Foster Victor Wealth Advisors, LLC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Foster Victor Wealth Advisors, LLC's GSK position evolved
Foster Victor Wealth Advisors, LLC first disclosed a stake in GSK in Q3 2023 at 144,000 shares (US$5.3M). The position peaked in Q1 2026 at 394,595 shares, worth US$23.4M. Across 13 filings, Foster Victor Wealth Advisors, LLC increased the stake 11 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 438,220 shares valued at US$21.7M — an increase of 23,934 shares quarter over quarter.. Notable position changes include a 44% increase in Q1 2024 (shares fell 10% over the following quarter), a 29% increase in Q4 2024 (shares rose 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 144.00K | $5.28M | New |
| Q4 2023 | 149.82K | $5.94M | Add |
| Q1 2024 | 216.45K | $8.83M | Add |
| Q2 2024 | 259.87K | $10.11M | Add |
| Q3 2024 | 272.92K | $10.98M | Add |
| Q4 2024 | 352.26K | $11.78M | Add |
| Q1 2025 | 352.31K | $12.20M | Hold |
| Q2 2025 | 363.69K | $14.20M | Add |
| Q3 2025 | 385.47K | $16.71M | Add |
| Q4 2025 | 391.20K | $18.86M | Add |
| Q1 2026 | 394.60K | $23.35M | Add |
| Q2 2026 | 414.29K | $21.23M | Add |
| Q3 2026 | 438.22K | $21.67M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC) is a Health Care company. 20 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.19M sh · $1.21B · Q3 2026
- JTC Employer Solutions Trustee Ltd 8.08M sh · $389.17M · Q3 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.92M sh · $188.73M · Q3 2026
- EQUITY INVESTMENT CORP 3.56M sh · $171.52M · Q3 2026
More on Foster Victor Wealth Advisors, LLC
FAQ
How long has Foster Victor Wealth Advisors, LLC held GSK?
Foster Victor Wealth Advisors, LLC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Foster Victor Wealth Advisors, LLC's current position in GSK?
As of Q3 2026, Foster Victor Wealth Advisors, LLC holds 438.22K shares of GSK (GSK PLC), valued at $21.67M, representing 1.09% of its reported portfolio and ranking #23.
Has Foster Victor Wealth Advisors, LLC been buying or selling GSK?
In the latest 13F filing (Q3 2026), Foster Victor Wealth Advisors, LLC increased its position in GSK. The position peaked in Q1 2026 at 394.60K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.